Brian William Corrigan PhD

Brian Corrigan, Vice President and Global Head of Clinical Pharmacology, and Head of Clinical Pharmacology for Global Product Development at Pfizer in Groton, Connecticut, sat down with our team virtually to talk about his career journey, his passion for Clinical Pharmacology and Pharmacometrics, and his thoughts on Canada’s life sciences ecosystem.

Corrigan has more than 20 years of experience in the application of Clinical Pharmacology and Pharmacometrics approaches that facilitate decision-making in all stages of drug development, most notably in the neurosciences and pain field. He has authored nearly 150 manuscripts, abstracts, and book chapters in this discipline. He received his B.Sc, Pharmacy with Distinction from the University of Alberta, Canada (1989), and Ph.D. in Pharmacokinetics from the University of Alberta (1996). He is also the recipient of the Distinguished Alumni Award for lifetime accomplishments in 2021, the Alumni Association’s highest honor. He is also a member of API’s Scientific Advisory Committee.

He has served as an editorial reviewer for numerous peer-reviewed journals, including Clinical Pharmacology and Therapeutics, and Alzheimer’s and Dementia. Brian served on the Editorial Advisory Board for Clinical Pharmacokinetics and Pharmacodynamics. He has also served as Co-chair of the modeling workgroup of the Coalition against Major Diseases (CAMD), a Critical Path Institute consortium of industry, FDA, NIH, medical associations, and patient advocacy groups working to develop a common understanding of neurological degenerative diseases. This led to the first submissions to the FDA and EMA for use of a disease model as a program independent drug development tool, and subsequent development of the fit-for-purpose regulatory pathway for drug development tools.